Kezar Life Sciences
40 hedge funds and large institutions have $20.5M invested in Kezar Life Sciences in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 41 → 40 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
40
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$973K | |
| 2 | +$299K | |
| 3 | +$64.5K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$35.8K |
| 5 |
Renaissance Technologies
New York
|
+$7.29K |
Top Sellers
| 1 | -$214K | |
| 2 | -$138K | |
| 3 | -$125K | |
| 4 |
Squarepoint
New York
|
-$99.1K |
| 5 |
CHAM
Clear Harbor Asset Management
Stamford,
Connecticut
|
-$77.1K |